Summary of product characteristics
Found 30 free book(s)1. SUMMARY OF PRODUCT CHARACTERISTICS
fs-1.5mpublishing.com1. summary of product characteristics registration file / december 2010 m + pac 1. summary of product characteristics . 1. name of the veterinary medicinal product
SmPC : summary of product characteristics
www.ema.europa.eu2. Summary of product characteristics. 1.What is the summary of product characteristics (SmPC)? • The SmPC is a legal document approved as part of the
VIMPAT - Summary of Product Characteristics
www.ucb.comVIMPAT® - Summary of Product Characteristics GPSRC CNS 197 S 0908 LCM Page 1 of 4 1. NAME OF THE MEDICINAL PRODUCT VIMPAT® 50 mg film-coated tablets . VIMPAT ® 100 mg film-coated tablets . VIMPAT ® 150 mg film-coated tablets
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ec.europa.euSUMMARY OF PRODUCT CHARACTERISTICS . 2 This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ether.stanford.eduSUMMARY OF PRODUCT CHARACTERISTICS. 2 1. NAME OF THE MEDICINAL PRODUCT Bridion 100mg/mLsolution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1mLcontains sugammadex sodium equivalent to 100mg sugammadex. Each vial of 2mLcontains sugammadex sodium equivalent to 200mg sugammadex.
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
pp.jazzpharma.com2 This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ec.europa.euSummary of the safety profile In five large longterm clinical tr ials over 2,500 patients have received treatment with Victoza alone or in combination with metformin, a sulfonylurea (with or without metformin) or metformin plus
Summary of Product Characteristics
www.aethoxysklerol-international.comSummary of Product Characteristics* *Translated from the German Summary of Product Characteristics. ol ® y since 2009. 1 Name of the medicinal products Aethoxysklerol® 0.25 % Aethoxysklerol® 0.5 % Aethoxysklerol® 1 % Aethoxysklerol® 2 % Aethoxysklerol® 3 % Active substance: lauromacrogol 400 (polidocanol)
Summary of Product Characteristics Amsidine - …
hemonc.orgSummary of Product Characteristics Amsidine Any unused product, any items that come into contact with the product and waste material must be ...
SUMMARY OF PRODUCT CHARACTERISTICS - …
db.cbg-meb.nlWELLBUTRIN XR Summary of Product Characteristics 1. NAME OF THE MEDICINAL PRODUCT WELLBUTRIN XR 150 mg modified release tablets. WELLBUTRIN XR 300 mg modified release tablets.
SUMMARY OF PRODUCT CHARACTERISTICS - …
db.cbg-meb.nlSummary of Product Characteristics (English version)_____ 4.6 Pregnancy and lactation Pregnancy The available data on the use of budesonide in pregnancy in women are not sufficient to evaluate the safety of the product. Foetal malformations were observed in animal studies.
SUMMARY OF PRODUCT CHARACTERISTICS - Sanofi
products.sanofi.co.uksummary of product characteristics 1 name of the medicinal product rapitil 2.0% w/v eye drops, solution 2 qualitative and quantitative composition
SUMMARY OF PRODUCT CHARACTERISTICS - © …
www.palliativedrugs.comSUMMARY OF PRODUCT CHARACTERISTICS 1. Name of the medicinal product OxyNorm 10 mg/ml, solution for injection or infusion 2. Qualitative and Quantitative Composition Oxycodone hydrochloride 10 mg/ml
SUMMARY OF PRODUCT CHARACTERISTICS - …
www.drreddys.comSUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Amlodipine 10mg Tablets . 2. QUALITATIVE AND QUANTITATIVE COMPOSITION . Each tablet contains amlodipine maleate equivalent to …
Summary of Product Characteristics - algeos.com
www.algeos.comsummary of product characteristics 1 name of the medicinal product scandonest 3% plain biocaine 3% plain, solution for injection 2 qualitative and quantitative composition
SUMMARY OF PRODUCT CHARACTERISTICS - …
clonmelhealthcare.ieSUMMARY OF PRODUCT CHARACTERISTICS . 1 NAME OF THE MEDICINAL PRODUCT Prednisolone 1mg Tablets . 2 QUALITATIVE AND QUANTITATIVE COMPOSITION . Each tablet contains 1 mg prednisolone.
Summary of Product Characteristics - FEIBA
www.feiba.comSummary of Product Characteristics ... Reconstitute the product as described in Section 6.6 and slowly inject or infuse it via the intravenous route. An injection speed of 2 U/kg body weight per minute must not be exceeded. 4.3 Contraindications
SUMMARY OF PRODUCT CHARACTERISTICS - Izotop
www.izotop.huSUMMARY OF PRODUCT CHARACTERISTICS substance is administered to one patient by mistake, it represents 0.43 mg/kg of 1. NAME OF THE MEDICINAL PRODUCT
SUMMARY OF PRODUCT CHARACTERISTICS 1. …
www.papaloizou.comConcor tabs 5mg+10mg SPC 14v073 MDS 10 - 1 - SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Concor 5 …
SUMMARY OF PRODUCT CHARACTERISTICS - Sanofi
www.sanofi-aventis.co.ukSUMMARY OF PRODUCT CHARACTERISTICS 1. Name of the medicinal product Epilim 100mg Crushable Tablets Epilim 200 Enteric …
SUMMARY OF PRODUCT CHARACTERISTICS - …
www.smith-nephew.comPage 1 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Zipzoc 20%, impregnated dressing 2. …
Summary of Product Characteristics (SmPC)
d3imrogdy81qei.cloudfront.netSUMMARY OF PRODUCT CHARACTERISTICS. 1. NAME OF THE MEDICINAL PRODUCT. Jext 150 micrograms solution for injection in pre-filled pen . Jext 300 micrograms solution for injection in pre-filled pen
SUMMARY OF PRODUCT CHARACTERISTICS
extranet.who.intArtesunate 60 mg for injection WHOPAR part 4 June 2013 (Guilin Pharmaceutical Co., Ltd.), MA051 . SUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS
cdsco.nic.inSummary of Product Characteristics lactating women may be considered after careful evaluation of the benefits and risks in case of a medical emergency or an epidemic.
SUMMARY OF PRODUCT CHARACTERISTICS - …
www.shijiebiaopin.net1.3.1 Summary of Product Characteristics FI/H/827/01/DC Proposed Version 6/9 • Betahistine affects the histaminergic system: Betahistine acts both as a partial histamine H 1-receptor agonist and histamine H 3-receptor antagonist also in …
SUMMARY OF PRODUCT CHARACTERISTICS
www.cdsco.nic.insummary of product characteristics weeks interval, 2 dose at least 2 weeks before delivery should be given during pregnancy so that protective antibody would be transferred to the infant in order to
SUMMARY OF PRODUCT CHARACTERISTICS
extranet.who.intThis product is intended for use in children. Nonetheless, safety information is provided with respect to adult health issues such as liver disease, pregnancy and lactation, to allow full access to all
SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.eu2 This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.
SUMMARY OF PRODUCT CHARACTERISTICS
pp.jazzpharma.comcontinued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed (see below).
ANNEX I SUMMARY OF PRODUCT …
www.zoetis.comThe accidental ingestion of the product may potentially result in adverse effects, such as transient excitatory neurological signs. To prevent children from accessing the product, only one chewable